论文部分内容阅读
目的:分析疏血通注射液与前列地尔注射液治疗脑梗死的临床疗效。方法:选取2011年8月—2013年8月我院收治的脑梗死患者60例,随机分为对照组和观察组,观察组给予疏血通注射液和前列地尔注射液治疗,对照组给予前列地尔注射液治疗,比较两组患者的临床疗效。结果:治疗后两组患者的凝血功能各项指标水平和血脂水平均比治疗前明显降低,P<0.05,观察组患者的总有效率明显高于对照组,P<0.05,具有统计学意义。结论:疏血通注射液与前列地尔注射液均具有抗血栓的效果,能抑制血小板聚集,增加脑血流量,改善微循环,促进神经功能恢复。疏血通注射液和前列地尔注射液联合应用的疗效优于单一应用前列地尔注射液的患者,且安全无毒副作用,值得推广应用。
Objective: To analyze the clinical curative effect of Shuxuetong injection and alprostadil injection on cerebral infarction. Methods: Sixty patients with cerebral infarction admitted to our hospital from August 2011 to August 2013 were randomly divided into control group and observation group. The observation group was treated with Shuxuetong injection and alprostadil injection, and the control group was given Alprostadil injection treatment, the clinical efficacy of two groups of patients were compared. Results: After treatment, the indexes of blood coagulation function and blood lipid level in both groups were significantly lower than those before treatment (P <0.05). The total effective rate in the observation group was significantly higher than that in the control group (P <0.05), with statistical significance. Conclusion: Shuxuetong injection and alprostadil injection have antithrombotic effect, can inhibit platelet aggregation, increase cerebral blood flow, improve microcirculation and promote neurological recovery. Shuxuetong injection and alprostadil injection combined with the effect is superior to single application of alprostadil injection in patients, and safe non-toxic side effects, it is worth promoting the application.